Association of dual SGLT-2 inhibitor and GLP-1 receptor agonist therapy with colon cancer risk in post-polypectomy patients with diabetes: a target trial emulation.
Saved in:
| Title: | Association of dual SGLT-2 inhibitor and GLP-1 receptor agonist therapy with colon cancer risk in post-polypectomy patients with diabetes: a target trial emulation. |
|---|---|
| Authors: | Wang CH; Division of Gastroenterology, Dept. of Internal Medicine, Kaohsiung Armed Forces General Hospital, Kaohsiung, Taiwan.; Division of Gastroenterology, Dept. of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan., Chang WC; Department of Ophthalmology, Universe Eye Center, Taiwan, Taipei., Chen HY; Department of Family Medicine, Chi Mei Medical Center, Tainan, Taiwan., Chen PH; Division of Hematology and Oncology, Dept. of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan.; Department of Oncology, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan., Lin MH; Division of Endocrinology and Metabolism, Dept. of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan. tim6801@msn.com., Lee CH; Division of Hematology and Oncology, Dept. of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan. drleechohao@gmail.com.; Department of Oncology, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan. drleechohao@gmail.com. |
| Source: | Diabetology & metabolic syndrome [Diabetol Metab Syndr] 2026 Mar 29; Vol. 18 (1). Date of Electronic Publication: 2026 Mar 29. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101488958 Publication Model: Electronic Cited Medium: Print ISSN: 1758-5996 (Print) Linking ISSN: 17585996 NLM ISO Abbreviation: Diabetol Metab Syndr Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
